Genetics Expert Talks about Tensions Between Parents and Regulators over Duchenne Treatments October 30, 2014

In a long feature story about the regulatory, economic, and personal impact of Duchenne muscular dystrophy, Eric Hoffman, PhD, Children's Research Institute, discusses the current tension that exists between families, wanting access to treatments and clinical trials, and the FDA.

Read the full story in Bloomberg Businessweek here. 

Latest Tweets